The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Galeterone to target proteasomal degradation of the androgen receptor in prostate tumor cells: A novel mechanism of action for treatment of AR-V7+ CRPC.
 
Daniel T. Dransfield
Employment - ArQule; Tokai Pharmaceuticals
Stock and Other Ownership Interests - ArQule
Patents, Royalties, Other Intellectual Property - ArQule; Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Tokai Pharmaceuticals
 
Douglas B Jacoby
Employment - Tokai Pharmaceuticals
Stock and Other Ownership Interests - Tokai Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Tokai Pharmaceuticals
 
Nivedita Namdev
Employment - Tokai Pharmaceuticals
Stock and Other Ownership Interests - ArQule
Consulting or Advisory Role - Tokai Pharmaceuticals
Patents, Royalties, Other Intellectual Property - ArQule
Travel, Accommodations, Expenses - Tokai Pharmaceuticals
 
Andrew Kwegyir-Afful
No Relationships to Disclose
 
Vincent Njar
Stock and Other Ownership Interests - Tokai Pharmaceuticals
Consulting or Advisory Role - Tokai Pharmaceuticals
Research Funding - Tokai Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Tokai Pharmaceuticals
Travel, Accommodations, Expenses - Tokai Pharmaceuticals